Adverum Biotechnologies Inc. buy Chardan Capital
Start price
17.04.25
/
50%
€1.38
Target price
17.04.26
€29.04
Performance (%)
-
End price
18.04.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Adverum Biotechnologies Inc. | - | - | - |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % |
Comments by Chardan_Capital for this prediction
In the thread Adverum Biotechnologies Inc. diskutieren
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its price target lowered by analysts at Chardan Capital from $40.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for ADVM provided by MarketBeat
In the thread Trading Adverum Biotechnologies Inc.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
13.08.25
13.08.25
€28.26
13.08.26
13.08.26
-
20.03.24
20.03.24
Stopped prediction by Chardan_Capital for Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
15.05.25
15.05.25
€29.48
15.05.26
15.05.26
-
16.05.26
16.05.26
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
19.07.24
19.07.24
€36.70
19.07.25
19.07.25
-
20.07.25
20.07.25
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.51
19.03.24
19.03.24
€3.68
19.03.25
19.03.25
-8.61%
20.03.25
20.03.25